Concurrent Gullain-Barre Syndrome and Acute Transverse Myelitis as an Initial Presentation of Systemic Lupus Erythematosus
0
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Systemic lupus erythematosus (SLE) is an autoimmune disorder involving multiple organs. Neuropsychiatric symptoms are frequently associated in SLE, which is referred to as neuropsychiatric SLE (NPSLE). NPSLE contains both central and peripheral nervous systems, which includes transverse myelitis, and Guillain-Barre syndrome (GBS). We report our experience of concurrent manifestation of transverse myelitis and GBS as an initial presentation of SLE, which suggests the common immune-mediated mechanisms of diseases. We here report the case of a 14-year-old boy with SLE who first presented with features of GBS. The patient developed ascending weakness starting from low extremities, experienced difficulty voiding, and had a facial rash. An initial diagnosis of GBS was made on the basis of clinical findings and nerve conduction studies. But he did not respond to intravenous immunoglobulin therapy and following spine MRI displayed T2 weighted high signal intensities from the cervical to thoracic region of the spinal cord, and serological analysis revealed the presence of antidsDNA, anti-smAb, anti nuclear antibody with decreased level of complements. The diagnosis was revised to GBS and acute transverse myelitis resulting from SLE. Additional methylprednisolone pulse therapy led to rapid clinical improvement. This was followed by oral prednisolone and cyclophosphamide pulse therapy. This is the first case of concurrent manifestation of GBS and transverse myelitis as initial presentation of SLE. The cross-reactivity of autoantibodies and increased susceptibility to infection owing to immunologic changes associated with lupus may form the basis of the association. Clinicians should consider a diagnosis of SLE as an etiology of GBS or transverse myelitis.
Abstract
Systemic lupus erythematosus (SLE) is an autoimmune disorder involving multiple organs. Neuropsychiatric symptoms are frequently associated in SLE, which is referred to as neuropsychiatric SLE (NPSLE). NPSLE contains both central and peripheral nervous systems, which includes transverse myelitis, and Guillain-Barre syndrome (GBS). We report our experience of concurrent manifestation of transverse myelitis and GBS as an initial presentation of SLE, which suggests the common immune-mediated mechanisms of diseases. We here report the case of a 14-year-old boy with SLE who first presented with features of GBS. The patient developed ascending weakness starting from low extremities, experienced difficulty voiding, and had a facial rash. An initial diagnosis of GBS was made on the basis of clinical findings and nerve conduction studies. But he did not respond to intravenous immunoglobulin therapy and following spine MRI displayed T2 weighted high signal intensities from the cervical to thoracic region of the spinal cord, and serological analysis revealed the presence of antidsDNA, anti-smAb, anti nuclear antibody with decreased level of complements. The diagnosis was revised to GBS and acute transverse myelitis resulting from SLE. Additional methylprednisolone pulse therapy led to rapid clinical improvement. This was followed by oral prednisolone and cyclophosphamide pulse therapy. This is the first case of concurrent manifestation of GBS and transverse myelitis as initial presentation of SLE. The cross-reactivity of autoantibodies and increased susceptibility to infection owing to immunologic changes associated with lupus may form the basis of the association. Clinicians should consider a diagnosis of SLE as an etiology of GBS or transverse myelitis.
참고문헌 (20)
- van Sorge NM, "Severity of Guillain-Barre syndrome is associated with Fc gamma Receptor III polymorphisms", J Neuroimmunol, 162, pp.157~164 (2005)
- Schulz SW, "Initial presentation of acute transverse myelitis in systemic lupus erythematosus: demographics, diagnosis, management and comparison to idiopathic cases", Rheumatol Int (2011)
- Tan EM, "The 1982revised criteria for the classification of systemic lupus erythematosus", Arthritis Rheum, 25, pp.1271~1277 (1982)
- Sibbitt WL, "The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus", J Rheumatol, 29, pp.1536~1542 (2002)
- Unterman A, "Neuropsychiatric Syndromes in Systemic Lupus Erythematosus:A Meta-Analysis", Semin Arthritis Rheum (2010)
- Petri M, "Review of classification criteria for systemic lupus erythematosus", Rheum Dis Clin North Am, 31, pp.245~254 (2005)
- "The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes", Arthritis Rheum, 42, pp.599~608 (1999)
- Ait Benhaddou E, "Acute Guillain-Barre-like polyradiculoneuritis revealing acute systemic lupus erythematosus: two case studies and review of the literature", Rev Neurol, 159, pp.300~306 (2003)
- Hsu TY, "Acute inflammatory demyelinating polyneuropathy as the initial presentation of lupus", Am J Emerg Med, 27, pp.900 e3~900 e5 (2009)
- Vaidya S, "Systemic lupus erythematosus and guillain-barre syndrome", J Clin Rheumatol, 5, pp.349~353 (1999)
- Muscal E, "Neurologic manifestations of systemic lupus erythematosus in children and adults", Neurol Clin, 28, pp.61~73 (2010)
- Israeli E, "Guillain-Barre Syndrome-A Classical Autoimmune Disease Triggered by Infection or Vaccination", Clin Rev Allergy Immunol (2010)
- Nakajima H, "Clinical manifestations of chronic inflammatory demyelinating polyneuropathy with anti-cardiolipin antibodies", Acta Neurol Scand, 111, pp.258~263 (2005)
- Dellavance A, "Anti-aquaporin-4 antibodies in the context of assorted immune-mediated diseases", Eur J Neurol, 19, pp.248~252 (2012)
- Lesprit P, "Prolonged remission of SLE-associated polyradiculoneuropathy after a single course of intravenous immunoglobulin", Scand J Rheumatol, 25, pp.177~179 (1996)
- "Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome. Plasma Exchange", Sandoglobulin Guillain-Barre Syndrome Trial Group, 1997, pp.349, 225~230
- Hughes RA, "Immunotherapy for Guillain-Barre syndrome: a systematic review", Brain, 130, pp.2245~2257 (2007)
- van Koningsveld R, "Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barre syndrome: randomised trial", Lancet, 363, pp.192~196 (2004)
- Polgar A, "Devic's syndrome and SLE: challenges in diagnosis and therapeutic possibilities based on two overlapping cases", Autoimmun Rev, 10, pp.171~174 (2011)
- Barile-Fabris L, "Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus", Ann Rheum Dis, 64, pp.620~625 (2005)